Table 3 The association between characteristics of the cohort and the positive number of the contralateral central cervical lymph node for unilateral cancer
Clinical characters | Number(%) | Contralateral central lymph node positive Number(%) | P value |
|---|---|---|---|
Gender | |||
 Female | 66(60.0) | 32(48.5) | 0.041 |
 Male | 44(40.0) | 30(68.2) |  |
Age | |||
  < 55 | 103(93.6) | 58(56.3) | 0.966 |
  >  = 55 | 7(6.4) | 4(57.1) |  |
BMI | |||
  <  = 23.9 | 63(57.3) | 33(52.4) | 0.329 |
  > 23.9 | 47(42.7) | 29(61.7) |  |
Multifocality | |||
 No | 85(77.3) | 48(56.5) | 0.967 |
 Yes | 25(22.7) | 14(56.0) |  |
T stage | Â | Â | 0.794 |
 T1,2,3a | 106(96.4) | 60(56.6) |  |
 T3b,4a,4b | 4(3.6) | 2(50.0) |  |
Ipsilateral central cervical lymphatic metastasis | |||
 No | 24(21.8) | 11(45.8) | 0.239 |
 Yes | 86(78.2) | 51(59.3) |  |
Contralateral central cervical lymph node | |||
 No | 48(43.6) |  |  |
 Yes | 62(56.4) |  |  |